Lupus anticoagulant testing: improvements in performance in a UKNEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods

被引:69
作者
Jennings, I
Greaves, M
Mackie, IJ
Kitchen, S
Woods, TAL
Preston, FE
机构
[1] UK NEQAS Blood Coagulat, Sheffield S10 2QN, S Yorkshire, England
[2] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland
[3] UCL, Dept Haematol, Haemostasis Res Unit, London, England
关键词
lupus anticoagulant; laboratory diagnosis; proficiency testing;
D O I
10.1046/j.1365-2141.2002.03821.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laboratory screening for lupus anticoagulant (LA) has been shown to be suboptimal in several studies. Guidelines have recently been published by an expert group for the British Committee for Standards in Haematology, in an attempt to standardize and improve screening procedures. The value of using screening tests conforming with these guidelines was investigated in a United Kingdom National External Quality Assessment Scheme (UK NEQAS) proficiency testing exercise. The correct diagnosis was achieved by 97% of laboratories for a LA-negative sample. However, 18.3% of centres reported a false-negative result for a sample from a LA-positive subject. A significantly higher proportion of centres that used methods conforming with the published guidelines achieved the correct diagnosis for this sample (P<0.002, chi-square test). A wide variety of screening tests were used by laboratories in this study. Within-method agreement could be improved by the use of a common normal pooled plasma to determine ratios. However, between-method agreement was not improved by this procedure. We conclude that adoption of methods compliant with national guidelines may improve the diagnosis of LA. There is a need, however, for reference and standardization materials to ensure further improvement in the accuracy of LA methods.
引用
收藏
页码:364 / 369
页数:6
相关论文
共 16 条
  • [1] Arnout J, 1999, THROMB HAEMOSTASIS, V81, P929
  • [2] Arnout J, 2001, THROMB HAEMOSTASIS, V86, P83
  • [3] OPTIMIZATION OF THE DILUTE PROTHROMBIN TIME FOR THE DETECTION OF THE LUPUS ANTICOAGULANT BY USE OF A RECOMBINANT TISSUE THROMBOPLASTIN
    ARNOUT, J
    VANRUSSELT, M
    HUYBRECHTS, E
    VERMYLEN, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (01) : 94 - 99
  • [4] Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
    Backos, M
    Rai, R
    Baxter, N
    Chilcott, IT
    Cohen, H
    Regan, L
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (02): : 102 - 107
  • [5] A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent
    Brancaccio, V
    Ames, PRJ
    Glynn, J
    Iannaccone, L
    Mackie, IJ
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (03) : 155 - 160
  • [6] BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
  • [7] The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
    Gardiner, C
    Mackie, IJ
    Malia, RG
    Jones, DW
    Winter, M
    Leeming, D
    Taberner, DA
    Machin, SJ
    Greaves, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) : 1230 - 1235
  • [8] Guidelines on the investigation and management of the antiphospholipid syndrome
    Greaves, M
    Cohen, H
    Machin, SJ
    Mackie, I
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (04) : 704 - 715
  • [9] Jacobsen EM, 2000, THROMB HAEMOSTASIS, V83, P704
  • [10] Jennings I, 1997, THROMB HAEMOSTASIS, V77, P934